Company profilePharmaceutical#676 of 1,318 in Pakistan1 DRAP alert

JANSSEN-CILAG

Pharmaceutical company · 15 brands · 15 molecules

Ranked #43 of 100 companies in Gastro

15 registered products 15 pharmaceutical brands 15 distinct molecules 1 DRAP alert

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

JANSSEN-CILAG is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 15 product registrations across 15 distinct molecules. Its portfolio is concentrated in Gastro and Antiemetics & Antinauseants. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by JANSSEN-CILAG

3 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Neuro 2

Stugeron Forte75MgRs 293.52 StugeronforteRs 309

Anti-Infectives 1

GynodaktarinvagRs 180.78

Top molecules by brand count

Ketoconazole2 brands

Domperidone2 brands

Miconazole2 brands

Econazole1 brand

Loperamide1 brand

Loperamide ...... 2 Mg1 brand

Flunarizine1 brand

Topiramate1 brand

Galantamine1 brand

Hydrocortisone1 brand

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

DRAP-official1 products · Rs 397.83 – Rs 397.83

DVAGO10 products · Rs 75.84 – Rs 950

Servaid8 products · Rs 122.73 – Rs 380

Median across source: Rs 220

Regulatory record

1 alert in the DRAP feed we track.

Drug Safety Alert: Risk of Neurodevelopmental Disorders in Children during Pregnancy with

2024-04-25

Competitive set

Companies whose registered portfolio overlaps most with this one.

MEDERA PHARMACEUTICALS (PVT) LTD.8 shared molecules

NEUTRO PHARMA (PVT) LTD.8 shared molecules

BIO LABS (PVT) LTD.6 shared molecules

VALOR PHARMACEUTICALS6 shared molecules

SHROOQ PHARMACEUTICALS6 shared molecules

Global Pharmaceuticals Pakistan6 shared molecules

Atco Pharma International (Pvt) Ltd6 shared molecules

Caliph Pharmaceuticals (Pvt) Ltd.6 shared molecules

GENOME PHARMACEUTICALS (PVT) LTD6 shared molecules

NABIQASIM INDUSTRIES (PVT) LTD.5 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

MEDERA PHARMACEUTICALS (PVT) LTD. holds 55 molecules not in this portfolio

NEUTRO PHARMA (PVT) LTD. holds 127 molecules not in this portfolio

BIO LABS (PVT) LTD. holds 139 molecules not in this portfolio

Get the full profile for JANSSEN-CILAG

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included